Previous Article | Next Article 
Journal of Clinical Microbiology, April 2004, p. 1855-1856, Vol. 42, No. 4
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.4.1855-1856.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Use of the BACTEC 9240 System with Mycosis-IC/F Blood Culture Bottles for Detection of Fungemia

LETTER
A recent study by Horvath et al. (
5) assessed the use of BACTEC
Plus Aerobic/F and Anaerobic/F blood culture (BC) bottles with
the BACTEC 9240 system to detect yeasts in a simulated-candidemia
model. The authors concluded that further research was needed
to optimize the recovery of
Candida spp. from this automated
BC system because of the high rate of false negatives and the
long time to detection (TTD), especially for
Candida glabrata.
We wish to comment on this study and report our own experience.
Firstly, a key point in fungal BCs is what components are included in the medium. Indeed, the difficulty of detecting some fungal species in traditional BC vials, because of their slow growth and/or weak production of CO2, has been reported in several studies (2, 8). A selective fungal medium, BACTEC Mycosis IC/F (Becton Dickinson, Sparks, Md.), was developed to achieve optimum recovery of yeasts and fungi from blood (3; N. Fujihara, T. Saito, S. Takakura, T. Kudo, Y. Iinuma, and S. Ishiyama, Abstr. 43rd Intersci. Conf. Antimicrob. Agents Chemother., abstr. M-1024, p. 461, 2003). The better performance of Mycosis IC/F is due to (i) a lysing agent which releases phagocytosed fungal cells; (ii) the addition of components which are essential to fungal growth, such as carbohydrates and yeast extract; (iii) and antibiotics that suppress bacterial overgrowth in blood samples containing both fungi and bacteria (R. Grillot, H. Fricker-Hidalgo, B. Lebeau, H. Pelloux, J. Croizé, C. Recule, and P. Ambroise-Thomas, Abstr. 39th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 975, p. 562, 1999). The mean time to yeast detection for simulated BCs (3), using the Mycosis IC/F medium, was 29.03 ± 13.99 h instead of 73.92 ± 56.74 h with aerobic Plus F medium (P = 0.0001). In the Grenoble (France) teaching hospital, we routinely use the European Community-labeled Mycosis IC/F medium commercially available in Europe. The fungal bottle is added to the traditional BC set when it is used for patients at risk of fungal infections. From January 2002 to November 2003, 11 episodes of candidemia out of 52 were due to C. glabrata (36 positive fungal bottles out of 118). They were detected with a mean TTD of 25.13 h. The importance of the fungal medium has also been proved in the diagnosis of disseminated infections due to filamentous fungi such as Fusarium spp. (4, 6).
Secondly, some points of the study of Horvath et al. may be criticized. Why perform this study with anaerobic bottles while the limited anaerobic growth capabilities of yeasts of medical interest are well known? (7). Moreover, the authors suggest the performance of terminal blind subcultures on the basis of the patient population to avoid a high rate of false negatives. This cannot be recommended in a routine mycology laboratory because of the delay in obtaining the final result, labor cost, and risk of exposure to infectious material.
According to the international consensus, defining opportunistic invasive fungal infections on a single BC yielding Candida species or other yeasts is a criterion of proven invasive fungal infection (1). Consequently, optimal conditions to rapidly and reliably detect yeasts and fungi from blood are crucial in the early diagnosis of invasive mycosis, a major cause of mortality in immunocompromised patients. Thus, we conclude that the aerobic Mycosis IC/F bottle monitored by BACTEC 9240 clearly enhances the sensitivity for fungemia detection and reduces the TTD.

REFERENCES
1 - Ascioglu, S., J. H. Rex, B. De Pauw, J. E. Bennett, J. Bille, F. Crokaert, D. W. Denning, J. P. Donnelly, J. E. Edwards, Z. Erjavec, D. Fiere, O. Lotholary, J. Maertens, J. F. Meis, T. F. Patterson, J. Ritter, D. Selleslag, P. M. Shah, D. A. Stevens, and T. J. Walsh. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:1-7.[Medline]
2 - Fricker-Hidalgo, H., A. Chirpaz-Cerbat, B. Lebeau, P. Ambroise-Thomas, and R. Grillot. 1997. Evaluation of BACTEC 9240 blood culture system by using the aerobic 9240 medium for fungemia detection. J. Mycol. Med. 7:128-133.
3 - Fricker-Hidalgo, H., F. Chazot, B. Lebeau, H. Pelloux, P. Ambroise-Thomas, and R. Grillot. 1998. Use of simulated blood cultures to compare a specific fungal medium with a standard microorganism medium for yeast detection. Eur. J. Clin. Microbiol. Infect. Dis. 17:113-116.[Medline]
4 - Hennequin, C., C. Ranaivoarimalala, T. Chouaki, M. Tazerout, T. Ancelle, J. J. Cabaud, and C. P. Raccurt. 2002. Comparison of aerobic standard medium with specific fungal medium for detecting Fusarium spp. in blood cultures. Eur. J. Clin. Microbiol. Infect. Dis. 21:748-750.[CrossRef][Medline]
5 - Horvath, L. L., D. R. Hospenthal, C. K. Murray, and D. P. Dooley. 2003. Detection of simulated candidemia by the BACTEC 9240 system with Plus Aerobic/F and Anaerobic/F blood cultures bottles. J. Clin. Microbiol. 41:4714-4717.[Abstract/Free Full Text]
6 - Letscher-Bru, V., F. Campos, J. Waller, R. Randriamahazaka, E. Candolfi, and R. Herbrecht. 2002. Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient. J. Clin. Microbiol. 40:1100-1102.[Abstract/Free Full Text]
7 - Odds, F. C. 1988. Candida and candidosis, 2nd ed., p. 61. Baillière Tindall, London, United Kingdom.
8 - Shigei, J. T., J. A. Shimabukuro, M. T. Pezzlo, L. M. De La Maza, and E. M. Peterson. 1995. Value of terminal subcultures for blood cultures monitored by BACTEC 9240. J. Clin. Microbiol. 33:1385-1388.[Abstract]
| | | | | |
Hélène Fricker-Hidalgo* Bernadette Lebeau Hervé Pelloux Renée Grillot
Service de Parasitologie-Mycologie Centre Hospitalier Universitaire, BP 217 38043 Grenoble, Cedex 9, France
|
| | | | | |
* Phone: 33 4 76 76 54 90, Fax: 33 4 76 76 56 60, E-mail: Hfricker-Hidalgo{at}chu-grenoble.fr |
Authors' Reply

LETTER
We agree with the comments of Fricker-Hidalgo and colleagues
regarding the use of specific mycology media with the BACTEC
9240 automated blood culture system to enhance the recovery
of yeasts. Our more recently published study (
1) evaluated the
recovery of
Candida spp. in the BACTEC 9240 system using another
specific mycology medium, BACTEC Myco/F Lytic (Becton Dickinson
and Company, Sparks, Md.). As one would suspect, the Myco/F
Lytic medium proved superior to either the standard aerobic
or anaerobic media, as did BACTEC Mycosis-IC/F. Although these
specific mycology media improve the recovery
Candida spp., their
routine clinical use has several limitations. Use of mycology
medium requires that additional blood be obtained from patients,
the use of an increased amount of laboratory space (including
valued incubator space), and the additional costs of processing
and purchasing bottles. The fungal medium bottles alone cost
approximately three times more than standard aerobic or anaerobic
medium bottles. Because of these limitations, many hospitals
do not routinely employ specific mycology medium for blood culture.
Our previous study (
2), being commented upon in their letter,
specifically evaluated candidemia detection using a standard
blood culture set of aerobic and anaerobic media. In most instances,
anaerobic medium was found to be inferior to aerobic medium,
as suggested. However, the anaerobic medium proved to be useful
in the recovery of
C. glabrata, which had a shorter time to
recovery in anaerobic versus aerobic medium (22.14 ±
2.47 h versus 120.89 ± 35.33 h, respectively). In patients
at high risk for candidemia, use of one of the mycology media
with the BACTEC 9240 system appears quite reasonable. However,
if mycology medium is not available, our study supports terminal
subculture as a potentially useful adjunctive step in these
high-risk patients.

REFERENCES
1 - Horvath, L. L., B. J. George, C. K. Murray, L. S. Harrison, and D. R. Hospenthal. 2004. Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for Candida growth detection. J. Clin. Microbiol. 42:115-118.[Abstract/Free Full Text]
2 - Horvath, L. L., D. R. Hospenthal, C. K. Murray, and D. P. Dooley. 2003. Detection of simulated candidemia by the BACTEC 9240 system with Plus Aerobic/F and Anaerobic/F blood culture bottles. J. Clin. Microbiol. 41:4714-4717.
| | | | | |
Lynn L. Horvath* Duane R. Hospenthal
Infectious Disease Service Brooke Army Medical Center Fort Sam Houston, TX 78234
|
| | | | | |
* Phone: (210) 916-5554, Fax: (210) 916-0388, E-mail: Lynn.Horvath{at}amedd.army.mil |
Journal of Clinical Microbiology, April 2004, p. 1855-1856, Vol. 42, No. 4
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.4.1855-1856.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Chiarini, A., Palmeri, A., Amato, T., Immordino, R., Distefano, S., Giammanco, A.
(2008). Detection of Bacterial and Yeast Species with the Bactec 9120 Automated System with Routine Use of Aerobic, Anaerobic, and Fungal Media. J. Clin. Microbiol.
46: 4029-4033
[Abstract]
[Full Text]